focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 May 2007 07:02

Phorm Inc21 May 2007 Embargoed for release until 7a.m. 21/05/07 Directorate Change Phorm, Inc ("Phorm" or the "Company") Further to the Company's previous announcement on 8th March 2007, the Company(AIM: PHRM and PHRX) is pleased to announce today that David Dorman, ChristopherLawrence and Virasb Vahidi have joined the Board of Phorm, Inc. David Dorman has been an advisor to the Company since July 2006. He is currentlysenior advisor and partner at global private equity firm Warburg Pincus and waspreviously chairman and chief executive officer of AT&T Corp. Before that, hewas CEO of Concert, the global venture created by AT&T and BritishTelecommunications. Mr Dorman serves on the Boards of Motorola, Inc., CVSCorporation, Firethorn Mobile, LLC, and YUM! Brands, Inc. Christopher Lawrence is currently vice chairman of Rothschild, Inc. Prior tojoining Rothschild in 2005, Mr Lawrence was chief strategic officer of CreditSuisse Group as well as a vice chairman of Credit Suisse First Boston. He beganhis investment banking career at Salomon Brothers in 1981. Virasb Vahidi, who is Phorm's chief operating officer, is an internationalbusiness executive with a distinguished career encompassing senior finance,strategy and planning roles in global companies including AT&T Corp. andAmerican Airlines, Inc. Mr Vahidi was most recently senior vice president ofcorporate strategy and development at AT&T, where he was the financial architectof the AT&T Corp/SBC Communications, Inc. merger and co-leader of theintegration team. As also notified on 8th March, David Svendsen, chairman, and Dave Gwozdz havestepped down from the Board of the Company. Dave Gwozdz will remain as US seniorvice president, Business Development and Sales for Phorm. Commenting on the new Board directors, Kent Ertugrul, chairman and CEO of Phorm,said: "We are delighted to welcome Dave, Chris and Virasb to the Board. Theyeach bring complementary skills and experience of an exceptional calibre. Theirwealth of expertise and knowledge will be invaluable as we continue to developour business." "We are grateful to David Svendsen and Dave Gwozdz for their contribution to theBoard and wish them well in the future." Save as set out in the Appendix, there are no further details in relation to theabove appointments which require disclosure under paragraph (g) of Schedule 2 tothe AIM Rules. Ends For EnquiriesPhorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Edelman Financial PR +44 20 7344 1325Paul Lockstone +44 7876 685200 Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb Notes to editors Phorm, Inc. was formerly known as 121Media Inc. Appendix Information provided in accordance with paragraph g of Schedule 2 to the AIMrules: (i) the director's full name and age together with any previous names; David Wyatt Dorman, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of DirectorshipAT&T 2002-2006CVS 2006-PresentFirethorn Mobile, LLC 2006-PresentMotorola 2006-PresentSABRE 1999-2002SAIC 1998-2002Scientific Atlanta 1998-2006Yum! Brands 2005-Present (i) the director's full name and age together with any previous names; Christopher Rueckert Lawrence, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of Directorship:120 East End Avenue 1997 (approximately)-Present (i) the director's full name and age together with any previous names; Virasb Vahidi, Age 40, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; None This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.